Page last updated: 2024-12-05

diethylenetriamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Diethylenetriamine (DETA) is a colorless, hygroscopic liquid with a strong ammonia-like odor. It is a versatile chemical with applications in various industries. DETA is a polyamine used in the production of chelating agents, epoxy resins, and polyamides. It is also used as a corrosion inhibitor, a fuel additive, and a catalyst in various chemical reactions. DETA is synthesized by reacting ethylene diamine with ammonia in the presence of a catalyst. DETA is a strong base and can react with acids to form salts. It is also a good ligand for metal ions, forming stable complexes. DETA is studied for its potential applications in various fields, including medicine, agriculture, and environmental science. It is used as a component in some pharmaceuticals and as a growth regulator in plants. DETA is also used in wastewater treatment to remove heavy metals and other pollutants. However, DETA is also a potential hazard due to its toxicity. It is corrosive to skin, eyes, and respiratory system. Exposure to high concentrations of DETA can lead to serious health problems. It is important to handle DETA with care and follow safety guidelines.'

diethylenetriamine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8111
CHEMBL ID303429
CHEBI ID30629
SCHEMBL ID15381
MeSH IDM0046898

Synonyms (117)

Synonym
CHEBI:30629 ,
1,2-ethanediamine, n-(2-aminoethyl)-
dien
n-(2-aminoethyl)ethane-1,2-diamine
diethylene triamine
einecs 203-865-4
1,5-diamino-3-azapentane
nsc 446
ancamine deta
diethylamine, 2,2'-diamino-
bis(beta-aminoethyl)amine
n-(2-aminoethyl)-1,2-ethanediamine
epicure t
un2079
chs-p 1
epon 3223
imino-bis-ethylamine
brn 0605314
2-(2-aminoethylamino)ethylamine
h 9506
2,2'-iminodi(ethylamine)
aminoethylethandiamine
deh 20
ccris 4794
ethylamine, 2,2'-iminobis-
diethylenetriamine [un2079] [corrosive]
1,4,7-triazaheptane
hsdb 525
2,2'-iminobis(ethanamine)
nsc446
ethylamine,2'-iminobis-
1, n-(2-aminoethyl)-
n,n-bis(2-aminoethyl)amine
(aminoethyl)ethanediamine
deta
bis(2-aminoethyl)amine
diethylamine,2'-diamino-
2,2'-diaminodiethylamine
barsamide 115
bis[.beta.-aminoethyl]amine
111-40-0
3-azapentane-1,5-diamine
ethylenediamine, n-(2-aminoethyl)-
diethylenetriamine
wln: z2m2z
nsc-446
inchi=1/c4h13n3/c5-1-3-7-4-2-6/h7h,1-6h
diethylenetriamine, reagentplus(r), 99%
stratospheres(tm) pl-deta (diethylenetriamine) resin, 50-100 mesh, extent of labeling: 6.0 mmol/g loading, 1 % cross-linked
NCGC00166036-01
D0493
CHEMBL303429 ,
n'-(2-aminoethyl)ethane-1,2-diamine
STK802352
AKOS000119987
NCGC00166036-02
tox21_303114
cas-111-40-0
NCGC00257198-01
dtxsid2025050 ,
dtxcid005050
tox21_201453
NCGC00259004-01
tox21_113096
n*1*-(2-amino-ethyl)-ethane-1,2-diamine
bdbm50323742
n1-(2-aminoethyl)ethane-1,2-diamine
BBL005239
03k6sx4v2j ,
1,2-ethanediamine, n1-(2-aminoethyl)-
ec 203-865-4
unii-03k6sx4v2j
4-04-00-01238 (beilstein handbook reference)
diethylenetriamine [un2079] [corrosive]
2,2'-iminodiethylamine
diethylenetriamine [hsdb]
diethylenetriamine [inci]
1,4,7-triaza-heptane
di-ethylenetriamine
diethylentriamine
SCHEMBL15381
BP-13436
n-(2-aminoethyl)ethylenediamine
.beta.,.beta.'-diaminodiethylamine
un 2079
2,2'-iminobisethylamine
deh 58 (salt/mix)
texacure ea-20
d.e.h. 20
deh 52 (salt/mix)
J-002573
J-520317
F2191-0291
n-(2-aminoethyl)1,2-ethanediamine
mfcd00008171
diethylenetriamine, saj first grade, >=98.0%
beta ,beta '-diaminodiethylamine
3-aza-1,5-diaminopentane
n-(2-aminoethyl)-ethylenediamine
bis(2-amino-ethyl)-amine
n-(2-aminoethyl)-1,2-ethanediamine, 9ci
n1-(2-aminoethyl)-1,2-ethanediamine
di(2-aminoethyl)amine
2,2'-diamino-diethylamine
bis[beta -aminoethyl]amine
2,2'-iminobis-ethylamine
2, 2'-diaminodiethylamine
2,2-iminodiethylamine
3-aza-1,5-pentanediamine
Q416728
VS-01562
bis-(2-amino-ethyl)-amine
EN300-19759
Z104475186
bis-(2-aminoethyl) amine
beta,beta'-diaminodiethylamine
ethylamine, 2,2'-iminobis-ethylenediamine, n-(2-aminoethyl)-

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Local delivery of DETA/NO via polymers is a safe and effective strategy for preventing cerebral vasospasm after SAH in this model."( Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats.
Clatterbuck, RE; Eberhart, CG; Gabikian, P; Tamargo, RJ; Tierney, TS; Tyler, BM, 2002
)
0.31
"Ethylenediamine dinitrate (EDDN) and diethylenetriamine trinitrate (DETN) are relatively insensitive explosive compounds that are being explored as safe alternatives to other more sensitive compounds."( Genotoxicity assessment of ethylenediamine dinitrate (EDDN) and diethylenetriamine trinitrate (DETN).
Johnson, MS; Kirby, P; Reddy, G; Song, J, 2011
)
0.88
" Thus, Alg-DETA/NO presented herein could serve as a safe and potent hydrogel dressing for the treatment of MRSA-infected wounds."( Diethylenetriamine/NONOate-doped alginate hydrogel with sustained nitric oxide release and minimal toxicity to accelerate healing of MRSA-infected wounds.
Ahn, HJ; Hasan, N; Jung, Y; Kim, H; Kim, MS; Kwak, D; Lee, J; Saparbayeva, A; Yoo, JW; Yoon, IS, 2021
)
2.06

Pharmacokinetics

ExcerptReferenceRelevance
" There were no significant differences in material balance or pharmacokinetic parameters among animals receiving DETA."( Pharmacokinetics and material balance studies of diethylenetriamine trihydrochloride in the Fischer 344 rat following oral, endotracheal or intravenous dosing.
Leung, HW; Tyler, TR,
)
0.39

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Decreases in food consumption were observed intermittently throughout the dosing period in both sexes at 15,000 ppm."( Effects of diethylenetriamine dihydrochloride following 13 weeks of dietary dosing in Fischer 344 rats.
Leung, HW; van Miller, JP, 1997
)
0.69
"3HCl) were studied with regard to route of administration and dosage effects."( Pharmacokinetics and material balance studies of diethylenetriamine trihydrochloride in the Fischer 344 rat following oral, endotracheal or intravenous dosing.
Leung, HW; Tyler, TR,
)
0.39
" Dose-response curves for spermine, spermidine, and diethylene-triamine (DET) show different potencies for inhibiting [3HDET."( [3H]Spermine binding to synaptosomal membranes from the chick retina.
Calderón, F; López, E; López-Colomé, AM; Pichardo, I, 1999
)
0.3
" Moreover, the cytotoxicity results against L929 fibroblast cell line revealed that p(ML) based particle are biocompatible up to 100 μg/mL with 85% cell viability regardless of their nature, and at 200 μg/mL dosage of p(ML), m-p(ML)/TA and m-p(ML)/DETA particles, the cell viabilities were determined as 83."( One step preparation of polymeric maltitol particles, from a sugar molecule, maltitol for biomedical applications.
Sahiner, N, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
triamineAny polyamine that contained three amino groups.
polyazaalkaneAny azaalkane in which two or more carbons in the chain are replaced by nitrogen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (28)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency3.54810.003245.467312,589.2998AID2517
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency17.74070.140911.194039.8107AID2451
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency5.62340.125919.1169125.8920AID2549
LuciferasePhotinus pyralis (common eastern firefly)Potency14.38180.007215.758889.3584AID624030
phosphopantetheinyl transferaseBacillus subtilisPotency3.16230.141337.9142100.0000AID1490
AR proteinHomo sapiens (human)Potency29.48880.000221.22318,912.5098AID743035; AID743053; AID743063
hypothetical protein, conservedTrypanosoma bruceiPotency14.12540.223911.245135.4813AID624173
estrogen nuclear receptor alphaHomo sapiens (human)Potency24.85250.000229.305416,493.5996AID743075; AID743080; AID743091
aryl hydrocarbon receptorHomo sapiens (human)Potency55.01150.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency26.60320.001723.839378.1014AID743083
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency15.84890.354828.065989.1251AID504847
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency23.71010.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency66.77000.000627.21521,122.0200AID743202; AID743219
DNA polymerase kappa isoform 1Homo sapiens (human)Potency1.06210.031622.3146100.0000AID588579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 12Homo sapiens (human)Ki11.40000.00021.10439.9000AID496922
Carbonic anhydrase 1Homo sapiens (human)Ki415.00000.00001.372610.0000AID496913
Carbonic anhydrase 2Homo sapiens (human)Ki118.00000.00000.72369.9200AID496914
Carbonic anhydrase 3Homo sapiens (human)Ki117.00000.00022.010210.0000AID496915
Cannabinoid receptor 1Rattus norvegicus (Norway rat)Ki11.50000.00020.566510.0000AID496923
Carbonic anhydrase 4Homo sapiens (human)Ki116.00000.00021.97209.9200AID496916
Carbonic anhydrase 6Homo sapiens (human)Ki11.50000.00011.47109.9200AID496919
Carbonic anhydrase 5A, mitochondrialHomo sapiens (human)Ki110.00000.00001.27259.9000AID496917
Carbonic anhydrase 7Homo sapiens (human)Ki12.10000.00021.37379.9000AID496920
Carbonic anhydrase 9Homo sapiens (human)Ki10.60000.00010.78749.9000AID496921
Carbonic anhydrase 15Mus musculus (house mouse)Ki105.00000.00091.884610.0000AID496925
Carbonic anhydrase 13Mus musculus (house mouse)Ki11.50000.00021.39749.9000AID496923
Carbonic anhydrase 14Homo sapiens (human)Ki10.10000.00021.50999.9000AID496924
Carbonic anhydrase 5B, mitochondrialHomo sapiens (human)Ki11.00000.00001.34129.9700AID496918
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (20)

Processvia Protein(s)Taxonomy
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
response to bacteriumCarbonic anhydrase 3Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 3Homo sapiens (human)
bicarbonate transportCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 4Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of bitter tasteCarbonic anhydrase 6Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 6Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 7Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 7Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 7Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 7Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 7Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 7Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 14Homo sapiens (human)
response to bacteriumCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 3Homo sapiens (human)
protein bindingCarbonic anhydrase 3Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 3Homo sapiens (human)
nickel cation bindingCarbonic anhydrase 3Homo sapiens (human)
protein bindingCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 6Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 6Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 14Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 14Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (25)

Processvia Protein(s)Taxonomy
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 3Homo sapiens (human)
cytosolCarbonic anhydrase 3Homo sapiens (human)
cytoplasmCarbonic anhydrase 3Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 4Homo sapiens (human)
rough endoplasmic reticulumCarbonic anhydrase 4Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentCarbonic anhydrase 4Homo sapiens (human)
Golgi apparatusCarbonic anhydrase 4Homo sapiens (human)
trans-Golgi networkCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
external side of plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cell surfaceCarbonic anhydrase 4Homo sapiens (human)
membraneCarbonic anhydrase 4Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 4Homo sapiens (human)
transport vesicle membraneCarbonic anhydrase 4Homo sapiens (human)
secretory granule membraneCarbonic anhydrase 4Homo sapiens (human)
brush border membraneCarbonic anhydrase 4Homo sapiens (human)
perinuclear region of cytoplasmCarbonic anhydrase 4Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
extracellular regionCarbonic anhydrase 6Homo sapiens (human)
extracellular spaceCarbonic anhydrase 6Homo sapiens (human)
cytosolCarbonic anhydrase 6Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 6Homo sapiens (human)
extracellular spaceCarbonic anhydrase 6Homo sapiens (human)
mitochondrial matrixCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
cytoplasmCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
cytosolCarbonic anhydrase 7Homo sapiens (human)
cytoplasmCarbonic anhydrase 7Homo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 14Homo sapiens (human)
membraneCarbonic anhydrase 14Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 14Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 14Homo sapiens (human)
plasma membraneCarbonic anhydrase 14Homo sapiens (human)
mitochondrionCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
mitochondrial matrixCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
cytoplasmCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID496919Inhibition of human carbonic anhydrase 6 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID496913Inhibition of human carbonic anhydrase 1 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID496914Inhibition of human carbonic anhydrase 2 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID496918Inhibition of human carbonic anhydrase 5B by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID1476430Antimigratory activity against human L3.6p1 cells at 1 uM after 24 hrs in presence of amine oxidase inhibitor aminoguanidine by scratch assay relative to control2017Journal of medicinal chemistry, 10-26, Volume: 60, Issue:20
Synthesis and Bioevaluation of Macrocycle-Polyamine Conjugates as Cell Migration Inhibitors.
AID496925Inhibition of mouse carbonic anhydrase 15 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID496923Inhibition of mouse carbonic anhydrase 13 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID496922Inhibition of human carbonic anhydrase 12 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID496917Inhibition of human carbonic anhydrase 5A by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID496920Inhibition of human carbonic anhydrase 7 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID74488Inhibitory activity against murine gelatinase B at 5 mM was determined2002Bioorganic & medicinal chemistry letters, Aug-19, Volume: 12, Issue:16
Design and synthesis of novel inhibitors of gelatinase B.
AID496924Inhibition of human carbonic anhydrase 14 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID496921Inhibition of human carbonic anhydrase 9 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID496916Inhibition of human carbonic anhydrase 4 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
AID496915Inhibition of human carbonic anhydrase 3 by stopped flow CO2 hydration method2010Journal of medicinal chemistry, Aug-12, Volume: 53, Issue:15
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (209)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (6.22)18.7374
1990's43 (20.57)18.2507
2000's56 (26.79)29.6817
2010's74 (35.41)24.3611
2020's23 (11.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 56.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index56.04 (24.57)
Research Supply Index5.42 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index91.63 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (56.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (1.35%)5.53%
Reviews2 (0.90%)6.00%
Case Studies6 (2.69%)4.05%
Observational0 (0.00%)0.25%
Other212 (95.07%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Intraoperative Gamma Probe Localization of the Ureter [NCT00587548]16 participants (Actual)Interventional2006-01-31Terminated(stopped due to Decided not pursue the study)
Abbreviated MRI (AMRI) vs. Ultrasound for HCC Surveillance in Cirrhosis [NCT04288323]Phase 4150 participants (Anticipated)Interventional2018-04-27Recruiting
A Phase II Study Evaluating Panitumumab-IRDye800 vs. Sentinel Node Biopsy and (Selective) Neck Dissection for Metastatic Lymph Node Identification in Patients With Head and Neck Cancer [NCT03405142]Phase 23 participants (Actual)Interventional2019-08-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT03405142 (1) [back to overview]Detection of Malignancy in Excised Lymph Nodes by Pathology or Labeling With Lymphoseek and/or Panitumumab-IRDye800

Detection of Malignancy in Excised Lymph Nodes by Pathology or Labeling With Lymphoseek and/or Panitumumab-IRDye800

After administration of panitumumab-IRDye800 alone or with Lymphoseek, lymph nodes potentially containing malignant tumor cells were surgically removed, and the lymph node tissue was evaluated for panitumumab-IRDye800 fluorescence intensity. For each subject, the 5 lymph nodes with the strongest fluorescence signal were tabulated against the Lymphoseek and histopathologic findings for those specific lymph nodes. For each of the 3 modalities, a positive finding is considered indicative of malignancy. The outcome is reported as the number of positive findings by modality for each cohort. The outcome is a number without dispersion. (NCT03405142)
Timeframe: Up to 30 days

,
InterventionLymph nodes (Number)
Panitumumab-IRDye800LymphoseekHistopathology
Any T Stage and Node-positive5NA0
T1 or T2 Stage and Node-negative1032

[back to top]